Creavo Medical Technologies is an innovative British company developing diagnostics technology for acute medical settings.

The company was set up to commercialise technology that was developed at the University of Leeds by Professor Ben Varcoe that will revolutionise front-line patient triage for chest pain; speeding decision-making, offering better patient management and crucially saving time and NHS resources.


Further Information

Interview: Prof Mark Kearney

Professor Mark Kearney talks about current guidelines and their implications.

Reducing diagnosis time for potential cardiac conditions

Watch Creavo Medical Technologies in a current-affairs style programme produced by ITN Productions in partnership with the NHS Alliance.

Interview: Dr Francis Morris

Dr Francis Morris talks about identifying patients with heart attacks.

Latest News


New device can rule out heart attacks in 3-5 minutes, saving £200m a year

We recently spoke to medical news website, Building Better Healthcare, about Vitalscan and how its technology has the potential to revolutionise the treatment of chest pain patients in A&E departments. Read more here.


Meeting the needs of the public sector with startup innovation

Read an article on Business Advice from our CEO Steve Parker which advises startup businesses on how to go about meeting the needs of the public sector. The article draws on Creavo’s own success in getting Vitalscan into an NHS multi-centre clinical trial. Click here to read the full article.


Battery-powered bedside scanner that takes just three minutes to detect if someone may have had a heart attack

Read some of the latest news coverage on our device, Vitalscan, in the Mail Online click here for the full article


Heart device on trial that could save the NHS £200 million a year

Read some of the latest news coverage on our device, Vitalscan, in the Health Tech Newspaper which discusses its current clinical trials and how it aims to combat some of the current statistics around chest pain patients in emergency departments. Click here for the full article.


Using quantum imaging to rule out cardiac conditions

Renowned medical news website, News-Medical.Net, recently conducted an interview with our CEO Steve Parker on Vitalscan and how it works to help rule out cardiac conditions in chest pain patients presenting to A&E. Read the full interview here.


Creavo Medical Technologies closes £13.4m ($17m) funding round

Creavo Medical Technologies, the UK-based med-tech company, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s funding target, reflecting strong investor support and endorsement of Creavo’s strategy and team. Led by IP Group plc, the developer of intellectual property-based businesses and working with investors from … Continue reading Creavo Medical Technologies closes £13.4m ($17m) funding round